Immunoregulatory intestinal microbiota and COVID-19 in patients with type two diabetes: a double-edged sword
Coronavirus disease 2019, or COVID-19, is a major challenge facing scientists worldwide.
Alongside the lungs, the system of organs comprising the GI tract is commonly targeted by …
Alongside the lungs, the system of organs comprising the GI tract is commonly targeted by …
Microbiota and its impact on the immune system in COVID-19—a narrative review
M Jabczyk, J Nowak, B Hudzik… - Journal of Clinical …, 2021 - mdpi.com
The microbiota is of interest for the development of a therapeutic strategy against SARS-CoV-
2 coronavirus disease 2019 (COVID-19) due to its impact on the host immune system …
2 coronavirus disease 2019 (COVID-19) due to its impact on the host immune system …
[HTML][HTML] Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential
H Xiang, QP Liu - World Journal of Gastroenterology, 2022 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious threat to global health …
respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious threat to global health …
Cross-talk between immune system and microbiota in COVID-19
S Baradaran Ghavami, M Pourhamzeh… - Expert review of …, 2021 - Taylor & Francis
Introduction Human gut microbiota plays a crucial role in providing protective responses
against pathogens, particularly by regulating immune system homeostasis. There is a …
against pathogens, particularly by regulating immune system homeostasis. There is a …
Modulated gut microbiota for potential COVID-19 prevention and treatment
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
gained global attention. SARS-CoV-2 identifies and invades human cells via angiotensin …
gained global attention. SARS-CoV-2 identifies and invades human cells via angiotensin …
Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
P Petakh, N Kobyliak, A Kamyshnyi - Frontiers in Cellular and Infection …, 2023 - frontiersin.org
Background The global pandemic of coronavirus disease 2019 (COVID-19) continues to
affect people around the world, with one of the most frequent comorbidities being Type 2 …
affect people around the world, with one of the most frequent comorbidities being Type 2 …
Microbiota modulation of the gut-lung axis in COVID-19
GLV de Oliveira, CNS Oliveira, CF Pinzan… - Frontiers in …, 2021 - frontiersin.org
COVID-19 is an infectious disease caused by the Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), and according to the World Health Organization (WHO), to …
Coronavirus-2 (SARS-CoV-2), and according to the World Health Organization (WHO), to …
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
The gastrointestinal tract is involved in coronavirus disease 2019 (COVID-19) caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …
Gut microbiota dysbiosis is a crucial player for the poor outcomes for COVID-19 in elderly, diabetic and hypertensive patients
NS Magalhães, W Savino, PMR Silva… - Frontiers in …, 2021 - frontiersin.org
A new infectious disease, named COVID-19, caused by the coronavirus associated to
severe acute respiratory syndrome (SARS-CoV-2) has become pandemic in 2020. The three …
severe acute respiratory syndrome (SARS-CoV-2) has become pandemic in 2020. The three …
Gut microbiota status in COVID-19: an unrecognized player?
S Donati Zeppa, D Agostini, G Piccoli… - Frontiers in cellular …, 2020 - frontiersin.org
Infection with the SARS-CoV-2 virus causes cardiopulmonary and vascular complications,
ranging in severity. Understanding the pathogenic mechanisms of the novel SARS-CoV2 …
ranging in severity. Understanding the pathogenic mechanisms of the novel SARS-CoV2 …